A Florida man has agreed to pay over $27 million to resolve allegations that he and his companies conspired with others to violate the False Claims Act by submitting false claims to, and receiving payments from, Medicare for cancer genomic (CGx) tests that were not medically necessary and were procured through illegal kickbacks, according to the Justice Department Friday.
Daniel Hurt, who owned or operated Fountain Health Services LLC, Verify Health, Landmark Diagnostics LLC, First Choice Laboratory LLC, and Sonoran Desert Pathology Associates LLC, also agreed to be excluded by the Department of Health and Human Services from Medicare, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.